Masimo Corporation (NASDAQ:MASI) has been assigned a consensus recommendation of “Hold” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $97.00.

A number of equities analysts have recently issued reports on MASI shares. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Monday, August 14th. Stifel Nicolaus started coverage on shares of Masimo Corporation in a research report on Monday, July 10th. They set a “buy” rating and a $105.00 target price on the stock. Roth Capital upped their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. BidaskClub upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating in a research report on Wednesday, July 12th. Finally, Zacks Investment Research upgraded shares of Masimo Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th.

Shares of Masimo Corporation (NASDAQ:MASI) traded up 0.26% on Friday, hitting $82.00. 721,140 shares of the stock were exchanged. The company has a 50 day moving average of $90.44 and a 200 day moving average of $90.72. Masimo Corporation has a 52-week low of $53.78 and a 52-week high of $104.71. The company has a market cap of $4.26 billion, a price-to-earnings ratio of 13.44 and a beta of 0.80.

Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company had revenue of $192.90 million for the quarter, compared to analyst estimates of $189.03 million. During the same period in the prior year, the business earned $0.57 earnings per share. Masimo Corporation’s quarterly revenue was up 11.8% on a year-over-year basis. Equities research analysts forecast that Masimo Corporation will post $2.80 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Masimo Corporation (MASI) Receives $97.00 Average PT from Analysts” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/29/masimo-corporation-masi-receives-97-00-average-pt-from-analysts.html.

In related news, COO Anand Sampath sold 40,000 shares of the stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the transaction, the chief operating officer now directly owns 20,000 shares in the company, valued at $1,840,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Sanford Fitch sold 6,000 shares of the stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total transaction of $551,340.00. Following the completion of the transaction, the director now owns 89,249 shares in the company, valued at $8,201,090.61. The disclosure for this sale can be found here. Insiders sold 126,000 shares of company stock worth $11,732,930 over the last 90 days. 16.60% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of Masimo Corporation by 4,676.3% in the first quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock valued at $686,789,000 after buying an additional 7,210,051 shares in the last quarter. Koch Industries Inc. raised its position in shares of Masimo Corporation by 5,053.7% in the second quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock valued at $439,000 after buying an additional 435,325 shares in the last quarter. State Street Corp raised its position in shares of Masimo Corporation by 42.8% in the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock valued at $130,704,000 after buying an additional 419,767 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Masimo Corporation by 28.0% in the second quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock valued at $163,356,000 after buying an additional 392,410 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its position in shares of Masimo Corporation by 76.3% in the second quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock valued at $73,191,000 after buying an additional 347,360 shares in the last quarter. Institutional investors and hedge funds own 83.27% of the company’s stock.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Analyst Recommendations for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.